You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 271 No. 14, April 13, 1994 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus

S. K. Garg, H. P. Chase, G. Marshall, S. L. Hoops, D. L. Holmes and W. E. Jackson
Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver 80262.

OBJECTIVE--To evaluate the effects of oral contraceptives (OCs) as a possible risk factor for early diabetic renal and/or retinal complications. DESIGN--A retrospective case-control study. SETTING--A university hospital diabetes clinic. PARTICIPANTS--Forty-three diabetic women who used OCs for 1 year or longer (mean, 3.4 years; range, 1.0 to 7.0 years) were compared with a computer-matched control group of 43 diabetic women who never used OCs. MAIN OUTCOME MEASURES--Hemoglobin A1c levels, albumin excretion rates, and mean retinopathy scores. RESULTS--The mean +/- SEM age and duration of diabetes were 22.7 +/- 0.5 years (range, 17.1 to 30.5 years) and 13.8 +/- 0.8 years, respectively, for the study group. The mean longitudinal hemoglobin A1c values were similar for study subjects and control subjects. The final mean albumin excretion rates, reflecting diabetic renal damage, and the mean eye grades were not significantly different between the groups. CONCLUSIONS--The use of OCs among young women with insulin-dependent diabetes mellitus does not pose an additional risk for the development of early diabetic retinopathy and/or nephropathy.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Contraception in Women with Medical Problems
JWatch Women's Health 2008;2008:2-2.
FULL TEXT  

Contraception After Gestational Diabetes
Damm et al.
Diabetes Care 2007;30:S236-S241.
FULL TEXT  

Oral Contraceptives, Angiotensin-Dependent Renal Vasoconstriction, and Risk of Diabetic Nephropathy
Ahmed et al.
Diabetes Care 2005;28:1988-1994.
ABSTRACT | FULL TEXT  

Effect of a Levonorgestrel Intrauterine System on Women With Type 1 Diabetes: A Randomized Trial
Rogovskaya et al.
Obstet Gynecol 2005;105:811-815.
ABSTRACT | FULL TEXT  

A systematic review of drug induced ocular reactions in diabetes
Hampson and Harvey
Br. J. Ophthalmol. 2000;84:144-149.
ABSTRACT | FULL TEXT  

Oral contraception and eye disease: findings in two large cohort studies
Vessey et al.
Br. J. Ophthalmol. 1998;82:538-542.
ABSTRACT | FULL TEXT  

Oral Contraception and Adolescent Women With Insulin-Dependent Diabetes Mellitus: Risks, Benefits, and Implications for Practice
Betschart
The Diabetes Educator 1996;22:374-378.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.